DNMT3A and acute myeloid leukemia: Figure 2e, f shows that for both genes, differential DNAm was directionally consistent for the CHIP and AML EWAS, with the majority of sites associated with DNMT3A CHIP showing decreased DNAm in both contexts and the majority of sites associated with TET2 CHIP showing increased DNAm in both contexts.